Epilepsy, Generalized
17
3
3
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
35%
6 trials in Phase 3/4
21%
3 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (17)
The Effect of Mandala Coloring on the Quality of Life in Epilepsy Patients: A Single Blind Randomized Controlled Study
Exercise for Memory Rehabilitation in Epilepsy
A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures
Baker Gordon Syndrome Natural History Study
Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness
ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Severity: Quantifying the Severity of Generalized Tonic-clonic Seizures (GTCS) With Connected Devices
Evaluation of the 24/7 EEG™ SubQ System in Subjects With Uncontrolled Genetic Generalised Epilepsy Syndrome
Helicobacter Pylori Eradication Therapy for Epileptic Children
Clinic to Community© Program for Adults With Epilepsy Admitted to Emergency Departments
Detecting Absence Seizures Using Eye Tracking
Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.
Clobazam in Patients With Lennox-Gastaut Syndrome
Clobazam in Subjects With Lennox-Gastaut Syndrome
A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy
A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy
Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients